Efficacy of dialectical behavior therapy and anti-anxiety drugs on functional dyspepsia

Phase 2

• Conditions: Functional dyspepsia.; Functional dyspepsia

• Registration Number: IRCT20171022036938N2
• Lead Sponsor: Birjand University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients aged between 18 and 50 years old
Patients who accepted to participate in the study after explaining the purposes of the study and advantages and disadvantages of the interventions
There should be the possibility to keep the type and dose of the medications fixed during the study
Having at least diploma education

Exclusion Criteria

Patients who do have psychotic or other simultaneous digestive disorders
Having full criteria of personality disorders
Patients who do not have alarm signs including gastrointestinal bleeding, blood in stool, fever, weight loss, anemia, diarrhea at night, severe abdominal pain and so on

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Functional dyspepsia severity. Timepoint: Before and right after the end of intervention. Method of measurement: Patient assessment of upper gastrointestinal symptom (PAGI-SYM) designed by Rentz in 2004; Made of 20 items,according to 6 degree classification 0 to 5 (no symptoms to very severe symptoms): no symptoms(0 to 20)- mild(21 to 40)- moderate(41 to 60)- sever(61 to 80)- very sever(81 to 100).

Secondary Outcome Measures

Name	Time	Method
Anxiety severity. Timepoint: Before and right after the end of intervention. Method of measurement: Anxiety score from beck anxiety inventory.